1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Insulin Delivery Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Insulin Delivery Market, EU5
3.1 Insulin Delivery Market, EU5, Revenue ($m), 2018-2033
3.2 Insulin Delivery Market, EU5, Revenue ($m), 2018-2033
3.3 Insulin Delivery Market, EU5, Volume (Units), 2018-2033
3.4 Insulin Delivery Market, EU5, Volume (Units), 2018-2033
3.5 Insulin Delivery Market, EU5, Company Share by Revenue ($m), 2025
4 Insulin Delivery Market, France
4.1 Insulin Delivery Market, France, Revenue ($m), 2018-2033
4.1.1 Insulin Pens Market, France, Revenue ($m), by Segment, 2018-2033
4.1.2 Insulin Pumps Market, France, Revenue ($m), by Segment, 2018-2033
4.2 Insulin Delivery Market, France, Volume (Units), 2018-2033
4.2.1 Insulin Pens Market, France, Volume (Units), by Segment, 2018-2033
4.2.2 Insulin Pumps Market, France, Volume (Units), by Segment, 2018-2033
4.3 Insulin Delivery Market, France, Average Price ($), 2018-2033
4.4 Insulin Delivery Market, France, Company Share by Revenue ($m), 2025
5 Insulin Delivery Market, Germany
5.1 Insulin Delivery Market, Germany, Revenue ($m), 2018-2033
5.1.1 Insulin Pens Market, Germany, Revenue ($m), by Segment, 2018-2033
5.1.2 Insulin Pumps Market, Germany, Revenue ($m), by Segment, 2018-2033
5.2 Insulin Delivery Market, Germany, Volume (Units), 2018-2033
5.2.1 Insulin Pens Market, Germany, Volume (Units), by Segment, 2018-2033
5.2.2 Insulin Pumps Market, Germany, Volume (Units), by Segment, 2018-2033
5.3 Insulin Delivery Market, Germany, Average Price ($), 2018-2033
5.4 Insulin Delivery Market, Germany, Company Share by Revenue ($m), 2025
6 Insulin Delivery Market, Italy
6.1 Insulin Delivery Market, Italy, Revenue ($m), 2018-2033
6.1.1 Insulin Pens Market, Italy, Revenue ($m), by Segment, 2018-2033
6.1.2 Insulin Pumps Market, Italy, Revenue ($m), by Segment, 2018-2033
6.2 Insulin Delivery Market, Italy, Volume (Units), 2018-2033
6.2.1 Insulin Pens Market, Italy, Volume (Units), by Segment, 2018-2033
6.2.2 Insulin Pumps Market, Italy, Volume (Units), by Segment, 2018-2033
6.3 Insulin Delivery Market, Italy, Average Price ($), 2018-2033
6.4 Insulin Delivery Market, Italy, Company Share by Revenue ($m), 2025
7 Insulin Delivery Market, Spain
7.1 Insulin Delivery Market, Spain, Revenue ($m), 2018-2033
7.1.1 Insulin Pens Market, Spain, Revenue ($m), by Segment, 2018-2033
7.1.2 Insulin Pumps Market, Spain, Revenue ($m), by Segment, 2018-2033
7.2 Insulin Delivery Market, Spain, Volume (Units), 2018-2033
7.2.1 Insulin Pens Market, Spain, Volume (Units), by Segment, 2018-2033
7.2.2 Insulin Pumps Market, Spain, Volume (Units), by Segment, 2018-2033
7.3 Insulin Delivery Market, Spain, Average Price ($), 2018-2033
7.4 Insulin Delivery Market, Spain, Company Share by Revenue ($m), 2025
8 Insulin Delivery Market, United Kingdom
8.1 Insulin Delivery Market, United Kingdom, Revenue ($m), 2018-2033
8.1.1 Insulin Pens Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
8.1.2 Insulin Pumps Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
8.2 Insulin Delivery Market, United Kingdom, Volume (Units), 2018-2033
8.2.1 Insulin Pens Market, United Kingdom, Volume (Units), by Segment, 2018-2033
8.2.2 Insulin Pumps Market, United Kingdom, Volume (Units), by Segment, 2018-2033
8.3 Insulin Delivery Market, United Kingdom, Average Price ($), 2018-2033
8.4 Insulin Delivery Market, United Kingdom, Company Share by Revenue ($m), 2025
9 Overview of Key Companies in EU5 Insulin Delivery Market
9.1 Sanofi
9.1.1 Company Overview
9.2 Novo Nordisk AS
9.2.1 Company Overview
9.3 Eli Lilly and Co
9.3.1 Company Overview
9.4 Medtronic Plc
9.4.1 Company Overview
9.5 F. Hoffmann-La Roche Ltd
9.5.1 Company Overview
9.6 Ypsomed Holding AG
9.6.1 Company Overview
9.7 Insulet Corp
9.7.1 Company Overview
10 Insulin Delivery Market Pipeline Products
11 Recent Developments
11.1 Corporate Communications
11.1.1 Nov 21, 2025: Johnson & Johnson Signs National Charter for Mental Health at Work
11.1.2 Oct 21, 2025: Novo Nordisk Foundation Proposes New Board Members for Novo Nordisk A/S
11.1.3 Oct 13, 2025: EASL CPGs Dissemination And Implementation Programme
11.1.4 Aug 19, 2025: Medtronic Appoints John Groetelaars and Bill Jellison as Independent Directors
11.1.5 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
11.1.6 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
11.2 Financial Announcements
11.2.1 Sep 12, 2025: Biodexa Pharmaceuticals Reports Interim Results for the Six Months Ended June 30, 2025
11.2.2 Aug 07, 2025: Lilly Announces Q2 2025 Results and Raises Guidance
11.2.3 Aug 07, 2025: Insulet Reports Second Quarter 2025 Revenue Increase of
32.9% Year-Over-Year (31.3% Constant Currency)
11.2.4 May 07, 2025: Medtronic to Announce Financial Results for Its Fourth Quarter and Full Fiscal Year 2025
11.2.5 Feb 05, 2025: Novo Nordisk Files Annual Report with the SEC
11.3 Government and Public Interest
11.3.1 Aug 29, 2025: Medtronic Executives to Speak at Upcoming Investor Conferences
11.3.2 May 23, 2025: Medtronic Chairman and CEO Geoff Martha to Speak at Bernstein's Strategic Decisions Conference
11.4 Other Significant Developments
11.4.1 Feb 04, 2025: As Major Insulin Producers Shift Focus, Rbio Steps up To Address Potential Shortages
11.4.2 Dec 20, 2024: Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite
11.5 Product News
11.5.1 Oct 31, 2025: New Project Aims to Transform Implantable Medical Devices
11.5.2 Oct 03, 2025: Hong Kong Grants Precision Medicine Patent to Diamyd Medical for Insulin Antigen Treatment in Type 1 Diabetes
11.5.3 Sep 29, 2025: Novo Nordisk Resubmits Awiqli® to the FDA for Once-Weekly Basal Insulin for Type 2 Diabetes
11.6 Strategy And Business Planning
11.6.1 Jun 27, 2025: Ypsomed opens production site in China
12 Appendix
12.1 Research Methodology
12.1.1 Coverage
12.1.2 Secondary Research
12.1.3 Primary Research
12.1.4 Market Modeling and Forecasting
12.1.5 Company Share Analysis
12.1.6 Benchmarking
12.2 GlobalData Consulting
12.3 Contact Us
12.4 Disclaimer